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Abstract
The environmental context in which psychostimulant drugs are administered can have a large effect on both their acute
psychomotor activating effects and their ability to induce the psychomotor sensitization associated with repeated drug administra-
tion. For example, the acute effects of amphetamine and the development of psychomotor sensitization to amphetamine and
cocaine are enhanced when they are administered in a distinct and relatively novel test environment, relative to when they are
given in the home cage, in the absence of any environmental stimuli predictive of drug administration. The experiments reported
here were designed to further examine this phenomenon and to test the hypothesis that the ability of a distinct context to promote
robust psychomotor sensitization is due to its ability to reliably signal (cue) drug administration. Specifically, we compared the
ability of contextual cues (a distinct test environment) and discrete cues (light, tone and/or odor), which both reliably predict drug
administration, to promote the induction of sensitization. The psychomotor stimulant effects (rotational behavior) of repeated
intravenous infusions of 0.5 mg/kg amphetamine were assessed in rats for whom drug treatments were signaled either: (1) by
placement into a distinct test environment; (2) by presentation of discrete cues; or (3) rats for whom drug treatments were given
in the home environment in the absence of any environmental cues. Amphetamine produced robust sensitization when given in
association with placement into a distinct test environment. The same treatment failed to produce sensitization when the drug was
given unsignaled in the animal’s home cage. Most importantly, signaling drug administration by presenting discrete cues was not
sufficient to promote the robust sensitization seen when treatments were given in a distinct test environment. These results confirm
that the induction of psychomotor sensitization can be powerfully modulated by environmental context and further establish that,
although contextual stimuli associated with a distinct test environment promote robust sensitization, discrete cues that merely
predict drug administration do not have this property. Possible reasons for the difference in the ability of contextual versus
discrete environmental cues to promote sensitization are discussed. © 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The effects of drugs of abuse, such as amphetamine
and cocaine, change when they are given repeatedly.
Some of their effects decrease, i.e. show tolerance,
whereas other effects increase, i.e. show sensitization
(for reviews see Refs. [76,84,87]). The psychomotor
stimulant effects of drugs typically sensitize with re-
peated drug treatment. For example, repeated intermit-
tent treatment with amphetamine or cocaine produces
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long-lasting sensitization of locomotor activity and
stereotyped behaviors in neurologically intact rats
[54,82] and rotational behavior in animals with a unilat-
eral lesion of the mesostriatal dopamine pathway
[31,73]. Also, the rewarding properties of amphetamine
and cocaine, that is, their ability to promote self-admin-
istration or a conditioned place preference, show sensi-
tization [47,53,65]. These findings have led to the
hypothesis that drug-induced neuroadaptations under-
lying sensitization may play an important role in the
induction and maintenance of the compulsive patterns
of drug-seeking behavior that characterize addiction
[75,77].
In part because of its potential role in addiction, and
in part because it is a compelling example of experi-
ence-dependent neuroplasticity, there has been consid-
erable interest in identifying variables that promote (or
retard) the induction of sensitization. Indeed, it is well
established that the magnitude of psychomotor sensi-
tization varies considerably depending on a number of
factors, including dose of the drug, treatment regimen
and the genotype of the test subject [74,76,87]. Further-
more, there is evidence that the context in which drugs
are administered (i.e. ‘set and setting’) can powerfully
modulate psychomotor sensitization [78]. Under some
experimental conditions, for example, the expression of
sensitization can come under strong conditioned stimu-
lus control [1,43,58,63,91,94]. In this case repeated ex-
posure to psychostimulant drugs may induce ‘neural
sensitization’, i.e. produce the relevant adaptations in
the nervous system, but the context in which a drug
challenge is given determines whether neural sensitiza-
tion is expressed behaviorally [63,78,88]. This phe-
nomenon is known as context- or environment-specific
sensitization. Less is known, however, about the role of
environmental context in modulating the ability of
drugs to produce sensitization-related neuroadaptations
in the first place [78]. In this case the issue is whether
environmental context can modulate the magnitude or
rate (the ‘induction’) of behavioral sensitization and not
whether behavioral sensitization is expressed or not (as
with context-specific sensitization).
In a series of studies, we have reported that the
susceptibility to psychomotor sensitization is enhanced
when amphetamine or cocaine are administered in a
distinct and relatively novel test environment, com-
pared to when the same drug treatment is given in the
animal’s home cage [5–7]. The effect of environmental
context is especially large when drug treatments are
given intravenously via a remote-controlled infusion
pump that eliminates exposure of the ‘home’ animals to
drug-related stimuli (e.g. the experimenter, handling, a
needle jab) [18,19,26,36]. Although these studies
demonstrate that environmental context can modulate
the induction of sensitization, they have not identified
the critical feature(s) of the environment that promote
(or retard) sensitization. In these experiments the
‘home’ and ‘novel’ environments were physically identi-
cal, excluding the possibility that the effect is due to
physical differences between the two environments. An-
other possibility is that a distinct environment facili-
tates the induction of sensitization by promoting
associative learning processes. It has been argued, for
example, that behavioral sensitization is due to treat-
ment-related stimuli acquiring conditioned stimulus
(CS), properties and thus, the ability to elicit a condi-
tioned response (CR) [43,63,69,91]. By this view, sensi-
tization occurs because with repeated drug treatments
the progressively increasing CR adds to the unchanging
unconditioned psychomotor drug effects. To the extent
that associative learning contributes to the induction of
sensitization, one would expect greater psychomotor
sensitization when drug injections are reliably signaled
by environmental cues (e.g. the treatment context), than
when there are no cues that predict drug administra-
tion. The major purpose of the experiments reported
here, therefore, was to further explore this ‘associative-
learning’ hypothesis.
In our previous experiments there were many contex-
tual cues associated with drug administration, including
tactile stimuli (transport and handling, the cage floor),
visual stimuli (the appearance of the testing room and
the test cage), auditory stimuli (white noise), olfactory
stimuli (the smell of bedding) and also the interoceptive
stimuli produced by the drug itself. Thus, by its very
nature a distinct test environment provides a complex,
multimodal contextual stimulus. The purpose of the
present experiments was to determine whether discrete
stimuli that predict drug administration would be simi-
larly effective at promoting robust sensitization. This
distinction between contextual cues and discrete cues
may be particularly relevant in light of recent concep-
tual developments in the field of learning theory regard-
ing the role of context in learning [12]. For example,
there is increasing evidence to suggest that conditioning
to contextual cues versus discrete cues is mediated by
different, albeit overlapping, neural systems [46,55,64].
Unfortunately, there is little published information
on the ability of discrete cues paired with experimenter-
administered drug injections to acquire conditioned
stimulus properties (for examples see Refs.
[33,61,66,93]), let alone to enhance sensitization. In the
present study, we addressed this issue by comparing the
rate and extent of psychomotor sensitization in three
groups of rats: (1) a group that received repeated i.v.
infusions of amphetamine following transport and
placement into a distinct and relatively novel test envi-
ronment (NOVEL); (2) a group that received repeated
i.v. infusions in their home cage during and following
presentation of discrete auditory, visual and/or olfac-
tory stimuli (HOME+); and (3) a group that received
repeated i.v. infusions of amphetamine in their home
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cage in the absence of any environmental stimuli
(HOME−). In Experiments 1–3, we used different com-
binations of visual, auditory and olfactory stimuli to
signal drug administration in the home cages. In Exper-
iment 4, we used a highly salient cue (a tone that had
previously been paired with footshock). To ensure that
the rats were alert during cue presentation in Experi-
ments 2 and 4, the test cages were vibrated (by remote
control) prior to cue presentation and drug administra-
tion. In all experiments, we used a remote-controlled
intravenous drug delivery procedure [22,66], which pro-
vides two major advantages over more traditional
routes of drug administration, such as intraperitoneal
injections. First, it allows maximal control over envi-
ronmental stimuli associated with drug administration.
Second, it allows drug administration without the po-
tentially stressful consequences of handling and a
needle jab.
We report that repeated intravenous injections of 0.5
mg/kg amphetamine failed to produce sensitization
when given in the absence of drug predictive cues. In
contrast, amphetamine produced robust sensitization
when drug administration was signaled by placement
into a distinct and relatively novel test environment.
Finally, amphetamine produced only very modest sensi-
tization when drug treatments were signaled by discrete
cues in the home cage. Taken together, these findings
indicate that discrete cues are not sufficient to produce
the robust sensitization that occurs when amphetamine
is given in association with placement into a distinct
test context. Possible reasons for this difference between
contextual and discrete stimuli are discussed.
2. Materials and methods
2.1. Subjects
Male Sprague–Dawley rats, purchased from Harlan
Sprague Dawley (Indianapolis, IN) were used in all
experiments. The rats weighed between 200 and 225 g
on arrival and were housed individually in stainless-
steel wire hanging cages in a climate controlled animal
colony, maintained on a 14:10 cycle (light:dark, lights
on at 08:00). Food and water were available ad libitum
for the duration of the experiment.
2.2. Beha6ioral measure
The psychomotor stimulant effects of amphetamine
were quantified by measuring amphetamine-induced ro-
tational behavior in rats with a unilateral lesion of the
nigrostriatal dopamine pathway [92]. The quantification
of rotational behavior provides a number of methodo-
logical advantages over more commonly used measures
of psychomotor activation, such as locomotor
crossover activity or stereotyped behaviors in neurolog-
ically intact rats [5,6,26]. Most importantly, in rats with
a unilateral lesion, a progressive increase in drug effect
is characterized by a progressive increase in rotational
behavior over a wide range of doses of amphetamine
[25,92]. In contrast, in neurologically intact rats, a
progressive increase in drug effect produces a progres-
sive increase in locomotor activity within only a narrow
range of doses of amphetamine [25,83]. As a conse-
quence, sensitization-dependent changes in psychomo-
tor stimulant effects are more readily detected using
rotational behavior in rats with a unilateral lesion
[25,73]. In addition, measuring rotational behavior is
particularly useful for studies investigating the effects of
the environment on psychomotor stimulant sensitiza-
tion because the unconditioned rotational response pro-
duced by exposure to a novel test environment alone is
small. In contrast, in neurologically intact rats, expo-
sure to a novel test environment can produce a very
large increase in locomotor crossover activity that may
conceal sensitization-dependent changes in psychomo-
tor activation [5,6].
2.3. Surgical procedures
Following a minimum of 7 days of acclimatization to
the animal colony, the rats were pretreated with at-
ropine methyl nitrate (5 mg/kg, i.p.) and then anes-
thetized with sodium pentobarbital (52 mg/kg, i.p., The
Butler Co., Columbus, OH), and supplemented with
methoxyflurane (Schering-Plough Animal Health
Corp., NJ) when necessary. Using standard stereotaxic
procedures, a 21-gauge stainless steel guide cannula was
positioned over the medial forebrain bundle. The fol-
lowing coordinates were measured from bregma: ante-
rior/posterior −3.0 mm; medial/lateral 91.8 mm, and
measured from skull surface: dorsal/ventral −1.0 mm.
In half of the rats, the cannula was placed over the left
hemisphere and in the other half over the right hemi-
sphere. In addition to the guide cannula, a length of
15-gauge stainless steel tubing and a length of
polyethylene tubing, both bent at a 90° angle were
positioned on the skull surface. These served as an
anchor for tethering and as a support for the intra-
venous catheter, respectively. The entire assembly was
affixed to the skull surface using jeweler screws and
dental cement. The guide cannula was capped with a
stainless steel stylet.
Following a 3-day recovery period, all rats received a
unilateral 6-hydroxydopamine (6-OHDA) lesion of the
nigrostriatal dopamine pathway using the following
procedures. 6-OHDA HBr was freshly dissolved (2
mg/ml) in a cold 0.9% NaCl and ascorbic acid (0.1
mg/ml) solution. Rats were pretreated with desipramine
hydrochloride (15 mg/kg, i.p.) to protect noradrenergic
terminals [16]. Between 20 and 30 min later, a 29 gauge
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infusion cannula was lowered, through the guide can-
nula, into the medial forebrain bundle (8.3 mm ventral
from skull surface) and 4 ml of 6-OHDA was infused
over an 8-min period (0.5 ml/min). The infusion cannula
was left in place an additional 2 min to minimize
diffusion upward the cannula tract.
Ten days after the 6-OHDA lesion, the rats were
screened for the development of dopamine receptor
supersensitivity (denervation supersensitivity) by ad-
ministering apomorphine (0.05 mg/kg, s.c. into the nape
of the neck) and measuring contraversive rotational
behavior. This dose of apomorphine produces vigorous
circling behavior only when \90% of the dopamine
input to the striatum has been lesioned unilaterally
[40,56]. Following the apomorphine injection (10 min)
the rats were observed and rats that made fewer than
five full rotations in a 1-min period were later re-le-
sioned and re-screened using identical procedures. Rats
that did not then meet the screening criterion were
excluded from the study.
Intravenous catheters were implanted using proce-
dures described previously [26,29]. Briefly, catheters
were constructed from silastic tubing (0.30 mm ID, 0.64
mm OD) and two sizes of polyethylene tubing (0.38
mm ID, 1.09 mm OD and 0.28 mm ID, 0.61 mm OD)
as described by Weeks [96]. Rats were anesthetized with
a combination of ethyl ether (to induce anesthesia) and
methoxyflurane (to maintain anesthesia) and the
catheter was implanted such that the silicone end was
inserted into the right external jugular vein and the
polyethylene end exited dorsally through the nape of
the neck. The catheter was then secured by inserting it
through the L-shaped length of polyethylene tubing
that had been affixed to the skull. Following catheter
implantation, the rats were allowed to recover for at
least 4 days before testing began. During this period,
the catheters were flushed daily with 0.1 ml of heparin
solution (30 U/ml, in 0.9% sterile saline buffered at
pH=7.4) and 0.1 ml of gentamicin (50 mg/ml) to
prevent occlusions and to circumvent microbial buildup
in the catheter. Throughout the experiments the
catheters were flushed once daily with 0.1 ml of hep-
arin. All drugs were purchased from Sigma (St. Louis,
MI) unless noted otherwise.
At the end of each experiment, the catheters were
tested for patency by injecting intravenously 0.1 ml of
the short-acting barbiturate Pentothal® (Thiopental
sodium, 20 mg/ml in sterile water). Rats that did not
become ataxic within 5 s were excluded from the
analyses.
2.4. Apparatus
The test cages consisted of plastic round buckets with
a flat-bottomed floor (diameter: 25 cm, height: 36 cm).
The floor of each cage was covered with granulated
corn-cob. Each rat was tethered via a length of
lightweight stainless steel cable to a home-made liquid
swivel [20], which was mounted on a counterbalanced
arm (Applied Concepts, Ann Arbor, MI). This allowed
the animal to move freely in the test cage. Syringe
pumps, programmed to infuse at a flow-rate of either
10 ml/min (Experiment 1) or 20 ml/min (Experiments
2–4) were located inside the testing room, but the
control equipment was located in an adjacent room.
Each test cage was equipped with a photocell based
automated rotometer (Applied Concepts, Ann Arbor,
MI), which recorded full turns (four consecutive 90°
turns) using an XT-based personal computer [59].
In Experiments 1 and 2, the HOME groups lived and
received drug treatments in cages equipped with a 5 W
circular white cue light (diameter: 1.5 cm) located :9
cm above the cage floor. These cue lights were normally
off, and provided the visual component of the drug
predictive cue (Experiments 1 and 2). A centrally lo-
cated speaker provided a constant white noise signal
(60 dB) to mask extraneous sounds. In Experiments
1–3, this speaker was also the source of the auditory
component of the drug predictive cue, which consisted
of a high pitched tone (85 dB). In Experiment 4, the
auditory cue (a 1-min burst of white noise) was pre-
sented through a small speaker mounted to the outside
wall of the test cage. The control modules for the cue
lights and the sound generators were located outside
the testing room. In Experiments 2 and 4, small remote-
controlled vibrators were attached to the outside wall
of each test cage and provided a vibratory cue. A more
detailed description of the different stimuli used in each
experiment is provided below.
2.5. Data analyses and statistics
The acute rotational response to amphetamine (first
test session) was analyzed for differences between
groups using a one-way analysis of variance (ANOVA),
followed by planned Fisher’s protected least significant
difference tests (PLSD). The development of psycho-
motor sensitization was evaluated using two indices.
The first index was provided by the change in rotational
behavior with successive injections of amphetamine (i.e.
a within-subjects measure of sensitization). As discussed
earlier, in rats with a unilateral lesion of the nigrostri-
atal dopamine pathway, an increase in drug effect is
characterized by a linear increase in rotational behavior
over a wide range of doses and therefore, changes in
drug effectiveness can be assessed by performing linear
regression analyses [5–7]. Sensitization is indicated by a
positive slope (slope coefficient \0), and the greater
the slope coefficient the greater the rate of sensitization.
Slope coefficient data for each group were analyzed
using one-sample t-tests and group differences were
determined using Student’s t-tests. The second index of
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sensitization was provided by comparing the behavioral
response to a challenge injection of amphetamine in
amphetamine-pretreated versus saline-pretreated rats
(i.e. a between-subjects measure of sensitization). With
this method sensitization is indicated by a significantly
greater response in amphetamine-pretreated than in
saline-pretreated rats. Group differences in the magni-
tude of sensitization were analyzed using two-way
ANOVAs (pretreatment drug-by-treatment condition),
followed by Fisher’s PLSD tests. Similarly, the response
to a challenge injection of saline (to test for the devel-
opment of a conditioned response) was analyzed using
two-way ANOVAs, followed by Fisher’s PLSD tests.
Finally, we also examined whether the rate of sensitiza-
tion was predicted either by the acute response (first
test session) to amphetamine, or, by the ability of
treatment related stimuli to acquire conditioned stimu-
lus properties. The hypothesis that the acute response
to amphetamine predicts the rate of sensitization was
tested with linear correlation analyses of rotational
scores on the first test session (acute response) versus
the slope coefficients (sensitization). The second hy-
pothesis was tested using a linear correlation analyses
of rotational scores on the saline challenge test (condi-
tioned response) versus the slope coefficients (sensitiza-
tion). These analyses were conducted on the pooled
data from Experiments 1–3 and are presented in Sec-
tion 6.2.
Detailed statistics are reported in the figure captions
in order to make the results sections easier to read.
However, no statements are made regarding group
differences in the results sections that are not supported
by significant statistical tests (PB0.05).
3. Experiment 1
We have reported previously that the susceptibility to
sensitization is enhanced when amphetamine treatments
are given in distinct test environment, relative to when
the same treatments are given in the absence of treat-
ment related stimuli, in the rat’s home cage [19,26,36].
It is possible that when given in a distinct context
amphetamine produces more robust behavioral sensi-
tization, because the context acts as a drug predictive
cue, thereby promoting associative learning processes.
The purpose of Experiment 1 was to determine whether
signaling drug administration using discrete cues would




All groups received drug treatments in physically
identical test cages, because the physical characteristics
of the test environment can have a large effect on both
the quantity and quality of the behavioral response to
drugs [15,32,79,89] and on the induction of sensitization
[44].
There were six independent groups: NOVEL(a) (N=
14), NOVEL(s) (N=13), HOME+ (a) (N=16),
HOME+ (s) (N=5), HOME− (a) (N=9), and HOME− (s)
(N=5). N refers to the number of animals per group
after verification of catheter patency.
3.1.1.1. NOVEL (s) and NOVEL (a) groups. These ani-
mals were housed in the main animal colony in wire-
hanging cages (see below) throughout the experiment.
Each test day, these rats were transported to a different
room and placed into the distinct test environment
described above, where within 10–120 s they received
an intravenous injection of either saline (NOVEL(s)) or
amphetamine (NOVEL(a)). Thus, for these rats drug
administration was signaled by the test context.
3.1.1.2. HOME+ (s) and HOME+ (a) groups. These ani-
mals lived in the test cages (see below), where they
received intravenous injections of saline (HOME+ (s)) or
amphetamine (HOME+ (a)) using remotely controlled
syringe pumps. In these groups drug administration
was paired with the presentation of a discrete com-
pound stimulus (see below).
3.1.1.3. HOME− (s) and HOME− (a) groups. These ani-
mals also lived in the test cages, where they received
intravenous injections of saline (HOME− (s)) or am-
phetamine (HOME− (a)) using remotely controlled sy-
ringe pumps. In these groups, however, stimulus
presentation and drug administration were always un-
paired (except on the amphetamine and saline challenge
tests, see Section 3.1.2). Thus, for these rats drug ad-
ministration was not signaled by any environmental
stimuli.
3.1.2. Procedures
3.1.2.1. Habituation. Immediately following catheter im-
plantation rats assigned to the HOME− and HOME+
groups were housed in test cages located in a climate-
controlled and sound-attenuated testing room and they
remained there for the duration of the experiment.
White noise was on at all times except during cue
presentation (see Section 3.1.2.2). Two days following
housing each rat was tethered, via a light-weight flexible
cable, to the liquid swivel mounted on a counter-bal-
anced arm. The rats remained tethered for the remain-
der of the experiment, except for short periods when
they were weighed. On the third day of the habituation
phase, these rats received the first of a series of three
unsignaled intravenous injections of heparin. This was
done in order to habituate them to the injection ritual.
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The following procedures were used. Each morning at
:8:00 h the experimenter entered the testing room and
filled the infusion line, consisting of a length of PE20
tubing, with heparin solution (30 U/ml). Next, the
catheters were manually flushed with 0.1 ml heparin (to
clear any obstructions) and connected to the liquid
swivel with PE20 tubing. A second length of PE20
tubing connected the swivel to a 1.0-ml syringe
mounted on a syringe pump. When all the infusion
lines had been connected to the catheters the animals
were left undisturbed. Later during the day, the
HOME+ and HOME− groups received an unsignaled
injection of 60 ml of heparin at a flow rate of 10 ml/min
by remotely activating the syringe pumps. At :18:00 h
the experimenter entered the testing room and the
infusion lines were disconnected, the catheters were
sealed and the cages were serviced when necessary.
During the habituation phase the rats in the NOVEL
groups remained undisturbed in the main animal
colony except that their catheters were flushed manu-
ally once each day with 0.1 ml of heparin solution.
These animals were housed in square stainless steel wire
hanging cages (18×25 cm) and the waste trays below
the cages were covered with pine-wood shavings.
3.1.2.2. Intermittent drug treatment. During the treat-
ment phase, all groups received nine consecutive daily
intravenous infusions of either 0.5 mg/kg D-am-
phetamine (NOVEL(a), HOME+ (a) and HOME− (a)) or
saline (NOVEL(s), HOME+ (s) and HOME− (s)), on a
schedule that consisted of one injection per day. This
dose of amphetamine has previously been shown to
produce a large acute response and robust psychomotor
sensitization when given in a distinct test environment
[19,78]. The treatment phase was interrupted on day 8
to test for the development of a conditioned response
(see Section 3.1.2.3). For the HOME− and HOME+
groups, the injection procedures were identical to those
used during the habituation phase of the experiment,
except that this time the infusion lines were loaded with
15 ml of amphetamine or saline. The remainder of the
infusion line was filled with heparin solution, which was
separated from the drug solution by a small air bubble
to prevent diffusion. After connecting the infusion lines
to the catheters the rats were again left undisturbed
until later during the day when the syringe pumps were
remotely activated. Because time of day may serve as a
drug predictive cue, rats were injected at different times
each test day, either at 11:00, 13:00 or 15:00 h (bal-
anced across treatment conditions). Each intravenous
injection consisted of an initial 20 ml of heparin (volume
of catheter), followed by 15 ml of amphetamine or
saline followed by an additional 25 ml of heparin. Thus,
the total injection volume was 60 ml, which was deliv-
ered at a flow rate of 10 ml/min, i.e. 6 min injection.
Although the entire infusion lasted 6 min, note that the
15-ml drug (or saline) bolus was injected over 90 s.
For rats assigned to the HOME+ condition drug
administration was paired with a 30-min presentation
of a compound stimulus consisting of a flashing light
and a discontinuous tone (cycling at :0.5 s on and 0.5
s off). These were presented simultaneously and pre-
ceded the drug injection by 1 min and remained on for
30 min (the white noise was turned off during this
period). Thus, for this group, drug administration was
always signaled by the presentation of this compound
stimulus. The HOME− groups were also exposed for
30 min to the light/tone stimulus, but, for these ani-
mals, cue presentation and drug administration were
always unpaired, i.e. sometimes the stimulus preceded
drug administration by :2 h, and sometimes the stim-
ulus followed drug administration by :2 h. At the end
of the day the infusion lines were disconnected, the
catheters were sealed and the testing room was secured
until the next day.
At approximately the same time of day as when the
HOME+ and HOME− groups received their injections,
animals in the NOVEL group were transported from
their home cages in the animal colony to a test room
containing cages that were physically identical to those
in which the HOME+ and HOME− animals lived.
Their catheters were manually flushed, the infusion
lines were loaded with amphetamine (NOVEL(a)) or
saline (NOVEL(s)) and were connected to the catheters
and the rats were tethered to the automated rotometers.
The two groups then received their respective intra-
venous treatments using the same injection procedures
and equipment as described above. No light/tone cue
was presented, because for this group placement into
the distinct test environment reliably signaled drug
administration. At the end of the test session the
NOVEL animals were disconnected from their tethers,
their catheters were sealed and they were returned to
the animal colony until the following day.
3.1.2.3. Saline challenge. As mentioned above, the treat-
ment phase of the experiment was interrupted on day 8
to test for the development of a conditioned response
by measuring rotational behavior in response to chal-
lenge injection of saline. All procedures were identical
to those described above, except that all groups re-
ceived an injection of saline, and, for both the HOME+
and HOME− groups, the injection was paired with the
presentation of the light/tone stimulus. Because the
unpaired presentation of the cue during the saline chal-
lenge could have reduced the associative strength be-
tween these stimuli and drug administration, all groups
were given two additional treatment injections of am-
phetamine (or saline), over the next 2 days.
3.1.2.4. Withdrawal and amphetamine challenge. Follow-
ing the last treatment day, drug treatment was discon-
tinued for 6 days. Following this withdrawal period,
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during which time animals were handled as in the
habituation phase, all groups (including the saline con-
trol groups) received a challenge i.v. infusion of 0.5
mg/kg of amphetamine to test for the expression of
sensitization. For both the HOME− and the HOME+
groups, drug administration was paired with stimulus
presentation on the challenge test day.
During each test session rotational behavior was
recorded in 5-min bins for a total of 90 min following
drug administration. For the HOME− and HOME+
groups rotational behavior was recorded during an
additional 15 min prior to drug administration to assess
baseline rotational activity.
3.2. Results: Experiment 1
Fig. 1 shows the effects on rotational behavior of
nine intravenous injections of 0.5 mg/kg amphetamine
or saline (panel A), a challenge injection of 0.5 mg/kg
amphetamine (panel C) and a challenge injection of
saline (panel D) given to rats: (i) after placement into
the novel test environment (NOVEL); (ii) in the home
cage when drug administration was signaled by a dis-
crete stimulus (HOME+); or (iii) in the home cage
when drug administration was unsignaled (HOME−).
For illustrative purposes Fig. 2 shows the time course
of rotational behavior following the first and ninth
injection of amphetamine (top panels) or saline (bottom
panels) and Fig. 3 shows the time course of rotational
behavior during the amphetamine (top panels) and
saline challenge tests (bottom panels).
The first and subsequent injections of saline pro-
duced no behavioral response in either the HOME− (s)
or HOME+ (s) groups (Fig. 1A), and these two groups
did not differ significantly at any time during the
experiment. Therefore, the data from these groups were
pooled to yield a single control group (HOME(s)).
Inspection of the time course data reveals that there
was a small increase in rotations during the first 5 min
of the first test session following placement into the
novel test environment (Fig. 2D). However, this effect
dissipated over test sessions presumably as a result of
habituation to the novel test environment.
An intravenous injection of amphetamine produced
an immediate increase in rotational behavior within the
first 5 min after the treatment (Fig. 2). This is consistent
Fig. 1. (A) The mean (9S.E.M.) number of rotations during the first,
second, fourth, fifth, eighth and ninth test session for rats that
received intravenous injections of saline or 0.5 mg/kg amphetamine.
The injections were given in association with either placement into a
distinct test environment (NOVEL(s) and NOVEL(a)), or in the home
cage in association with the presentation of discrete stimuli (HOME(s)
and HOME+ (a)), or in the home cage, but unsignaled (HOME(s) and
HOME− (a)). The first and subsequent injections of saline in all three
treatment conditions produced negligible rotational behavior during
any of the test sessions. A one-way ANOVA indicated that there was
a significant effect of group on the first test session (F=25.1,
PB0.0001). The initial injection of amphetamine produced a signifi-
cant increase in rotational behavior in the NOVEL(a) and HOME+ (a)
groups (Fisher’s PLSD, PB0.01), but not in the HOME− group.
Furthermore, the acute response was greater in the NOVEL(a) than in
the HOME+ (a) group (Fisher’s PLSD, PB0.0001) and the latter
group did not differ significantly from the HOME− (a) group. (B) The
results of the linear regression analysis indicate that only the
NOVEL(a) group showed an increase in rotations over test sessions,
i.e. sensitization (one-sample t-test, mean9S.E.M. slope coeffi-
cient=13.26, t=5.4, PB0.0001). (C) Mean (9S.E.M.) number of
rotations on the amphetamine challenge day for rats pretreated with
amphetamine or saline in the NOVEL, HOME+ or HOME− condi-
tions. A one-way ANOVA indicated that there was a significant effect
of group (F=29.2, PB0.0001). Rats in the NOVEL and HOME+
groups, and pretreated with amphetamine, showed a greater response
than saline-pretreated rats (Fisher’s PLSD, PB0.05), indicating that
these groups were sensitized. The magnitude of sensitization was
greater in the NOVEL(a) group than in the HOME+ (a) group, as
indicated by a significant interaction effect (two-way ANOVA, effect
of drug, F=34.5, PB0.0001; effect of condition, F=55.4, PB0.05;
effect drug-by-condition, F=9.6, PB0.01). Furthermore, the re-
sponse of the HOME+ (a) and HOME− (a) groups did not differ. (D)
Mean (9S.E.M.) number of rotations during the first 15 min of the
saline challenge test for rats in the NOVEL, HOME+ or HOME−
groups. A one-way ANOVA indicated a significant effect of group
(F=29.7, PB0.01). Rats in the NOVEL and HOME+ groups that
were pretreated with amphetamine showed a greater rotational re-
sponse than their respective saline-pretreated groups, i.e. these groups
showed a conditioned response (Fisher’s PLSD, PB0.05). The mag-
nitude of the conditioned response in the NOVEL(a) group was
greater than in the HOME+ (a) group, as indicated by a significant
interaction effect (two-way ANOVA, effect of pretreatment drug,
F=34.9, PB0.0001; effect of condition, F=40.2, PB0.0001; effects
of drug-by-condition, F=8.5, PB0.01). Furthermore, the response
of the HOME+ (a) and HOME− (a) groups did not differ.Fig. 1.
H.S. Crombag et al. / Beha6ioural Brain Research 116 (2000) 1–228
with reports showing a rapid rise in plasma and brain
concentrations of amphetamine and the extracellular
concentrations of dopamine following intravenous in-
jections in rats [24,28]. The effects of an acute intra-
venous injection of 0.5 mg/kg amphetamine can be seen
by examining the data for test session 1 (Fig. 1A).
There were large group differences in the effect of the
first injection of amphetamine, as indicated by a one-
way ANOVA. Both the NOVEL(a) and HOME+ (a)
groups made significantly more rotations after an injec-
tion of amphetamine than the saline control groups or
the HOME− (a) group (Fisher’s PLSD, PB0.05). In the
latter group, amphetamine did not produce a significant
increase in rotational behavior, relative to the saline
control group. Furthermore, amphetamine had a
greater acute effect in the NOVEL group than in the
HOME+ group. Inspection of the time course data
shows that in the NOVEL condition the early peak in
activity was followed by a small decline in rotations,
followed by a second peak in activity :20–30 min
after the injection (Fig. 2A). In contrast, in the
HOME+ (a) (and HOME− (a)) groups, amphetamine
produced only a small and brief increase in rotational
behavior and the response was characterized by a single
initial peak in behavior, followed by a rapid return to
baseline levels of activity (Fig. 2B,C).
The effects of repeated injections of amphetamine
were assessed using linear regression analyses, and the
results are shown in Fig. 1B. There were large group
differences in the response to repeated injections of
amphetamine. In the NOVEL(a) group there was a
progressive increase in rotational behavior across test
sessions, as indicated by a significant positive slope
(mean9S.E.M. slope coefficient=13.2692.65, PB
0.001). In the HOME− (a) or HOME+ (a) groups re-
peated injections of amphetamine did not produce a
statistically significant increase in rotations (i.e. the
slopes were not different from 0), and these groups did
not differ from each other (mean9S.E.M. slope coeffi-
cients: HOME− (a)=3.4791.769, P=0.10,
HOME+ (a)=1.72691.189, P=0.16). The time course
data show that for the NOVEL(a) group sensitization
was characterized by a large increase in the magnitude
of the initial behavioral response, which persisted
throughout the first hour of the test session (Fig. 2A).
The mean number of rotations seen following the
saline challenge were averaged over the first 15 min
following injection (Fig. 1D), because this captured the
entire time course of the conditioned response (Fig. 3,
bottom panels). Both the NOVEL(a) and HOME+ (a)
groups showed a greater response than the saline con-
trol group, indicating that these groups developed a
conditioned response (to contextual or discrete stimuli,
respectively). The magnitude of the conditioned re-
sponse, however, was significantly greater in the
NOVEL(a) group than in the HOME+ (a) group, as
indicated by a significant drug (pretreatment)-by-condi-
tion interaction (Fig. 1D). Also, the HOME+ (a) group
did not differ significantly from the HOME− (a) group.
As expected, the HOME− (a) group did not show a
conditioned response following presentation of the
light/tone stimulus.
Finally, on the amphetamine challenge test session
amphetamine-pretreated rats showed greater rotational
behavior than saline-pretreated rats, in both the
NOVEL(a) and HOME+ (a) groups (Fig. 1C). In other
words, both groups sensitized to the psychomotor stim-
Fig. 2. The mean (9S.E.M.) number of rotations per 5-min interval
in response to the first (light circles) and ninth (dark circles) injection
of 0.5 mg/kg amphetamine (top panels) or saline (bottom panels) in
the NOVEL, HOME+ or HOME− groups. The asterisks indicate a
significant (PB0.05) difference in rotations between the first and
ninth test session for each time interval (paired Student’s t-tests).
Fig. 3. The mean (9S.E.M.) number of rotations per 5-min interval
in response to a challenge injection of 0.5 mg/kg amphetamine (top
panels) or saline (bottom panels). For both the HOME+ and
HOME− groups the saline and amphetamine challenge injections
were paired with presentation of the light and tone stimuli. The
asterisks indicate a significant (PB0.05) difference in rotations be-
tween saline and amphetamine pretreated groups during each time
interval (unpaired Student’s t-tests).
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ulant effects of amphetamine. However, the magnitude
of the sensitized response was significantly greater in
the NOVEL(a) group than in the HOME+ (a) group, as
indicated by a significant drug (pretreatment)-by-condi-
tion interaction. In both of these groups, behavioral
sensitization was characterized by an increase in the
early peak drug response (Fig. 3A and C). Note, how-
ever, that the HOME+ (a) did not differ significantly
from the HOME− (a) group and this latter group did
not show a significantly greater response than saline
pretreated rats, confirming that these rats did not sensi-
tize (Fig. 1C).
4. Experiment 2
Experiment 1 indicated that discrete drug-paired cues
did not promote robust sensitization, but had only a
very modest effect. It is possible, however, that the
relatively small effect of discrete cues in promoting
sensitization was because either the stimuli used were
not optimal or there were too few pairings between
drug injections and the drug predictive stimuli. In Ex-
periment 2, therefore, we examined the effects of 20
(versus nine in Experiment 1) intravenous injections of
amphetamine (or saline) in all groups. Additionally, the
compound stimulus was modified in an attempt to
increase its effectiveness. First, it is possible that in
Experiment 1 the stimulus was not especially effective
because of the overshadowing of one stimulus element
(light) by the second element (the tone), a phenomenon
sometimes observed with compound stimuli [48,62].
Therefore, in the present experiment we decided to use
a compound stimulus consisting of alternating repeti-
tions of a flashing light and a tone. Second, the tempo-
ral relationship between the stimulus and drug effect
was altered so that cue presentation would better coin-
cide with the peak drug effect, because this may pro-
mote more robust learning. Finally, in Experiment 1 we
observed that some rats in the HOME− and HOME+
groups appeared to be inattentive during drug adminis-
tration. Thus, in this experiment we devised a method
to arouse the rats prior to drug administration and cue
presentation by remotely vibrating the test cages.
4.1. Methods
The techniques and testing procedures were similar
to those used in the previous experiment. Briefly, the
following experimental groups were used: NOVEL(a)
(N=11), NOVEL(s) (N=12), HOME+ (a) (N=9),
HOME+ (s) (N=4), HOME− (a) (N=11), and finally
HOME− (s) (N=4). Following the 5-day habituation
phase, the rats received 20 daily intravenous injections
of either 0.5 mg/kg amphetamine or saline. Again, each
injection again consisted of 20 ml of heparin, followed
by 15 ml of amphetamine solution (0.5 mg/kg) or saline
followed by an additional 25 ml of heparin solution.
However, in this experiment the solution was injected at
a flow-rate of 20 ml/min, and therefore, the bolus of
drug solution was injected over 45 s. As in Experiment
1, both the HOME− and the HOME+ groups were
exposed to the compound stimulus consisting of alter-
nating periods of a light stimulus (10 s), followed by a
pulsing tone (85 dB, 10 s). For the HOME+ groups the
stimulus preceded drug (or saline) administration by 10
s and remained on for 10 min following drug adminis-
tration. For the HOME− groups drug (or saline) ad-
ministration and stimulus presentation were always
unpaired, except during the challenge test, as in Exper-
iment 1. Finally, 1 min prior to stimulus onset (in the
HOME+ groups) or unsignaled drug administration (in
the HOME− groups) the test cages were vibrated by
remotely activating a small vibrator attached to each
test cage (three pulses of 1 s duration each). Video
observation confirmed that this technique alerted the
animals prior to drug administration, as indicated by
orienting movements and head scanning behavior. The
NOVEL groups were handled and tested using identical
procedures as described for Experiment 1.
Following a 10-day withdrawal period, all groups
were given a challenge injection of 0.5 mg/kg am-
phetamine to test for the expression of sensitization.
The day after this, all groups were tested for the
development of a conditioned response by measuring
rotational behavior in response to a challenge injection
of saline. During the amphetamine and saline challenge
tests drug administration for both the HOME− and
HOME+ groups was paired with presentation of the
light/tone stimulus. Furthermore, for the saline chal-
lenge test the compound cue was presented continu-
ously during the first hour of the test session.
Rotational behavior was recorded for 120 min in
5-min bins. For the HOME− and HOME+ groups
rotational behavior was recorded for an additional 15
min prior to drug administration to measure baseline
activity.
4.2. Results: Experiment 2
Fig. 4 shows the effects of 20 intravenous infusions of
0.5 mg/kg of amphetamine or saline (panel A), a chal-
lenge infusion of 0.5 mg/kg amphetamine (panel C) or
a challenge infusion of saline (panel D) given to rats: (i)
after placement into the novel test environment
(NOVEL); (ii) in the home cage where drug administra-
tion was signaled by discrete stimuli (HOME+); or (iii)
in the home cage where drug administration was
unsignaled (HOME−). For illustrative purposes Fig. 5
shows the time course of rotational behavior following
the 1st and 20th injection of amphetamine (top panels)
or saline (bottom panels) and Fig. 6 shows the time
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Fig. 4. (A) The mean (9S.E.M.) number of rotations during the first,
fifth, tenth and twentieth test session for rats that received intravenous
injections of saline or 0.5 mg/kg amphetamine. The groups are the same
as in Fig. 1. The first and subsequent injections of saline produced
negligible rotational behavior in all groups. A one-way ANOVA
indicated that there was a significant effect of group during the first
test session (F=51.1, PB0.0001). The first injection of amphetamine
produced a significant increase in rotational behavior in both the
NOVEL(a) and HOME+ (a) groups (Fisher’s PLSD, PB0.01), but not
in the HOME− (a) group. Furthermore, the acute response to am-
phetamine was greater in the NOVEL(a) group than in the HOME+ (a)
group (Fisher’s PLSD, PB0.05), and the latter group did not differ
significantly from the HOME− (a) group. (B) The results of the linear
regression analyses indicated that the NOVEL(a) and HOME+ (a)
groups showed an increase in rotations over test sessions, i.e. sensitiza-
tion (NOVEL(a), mean9S.E.M. slope coefficient=9.53, t=5.4, PB
0.001; HOME+ (a), mean9S.E.M. slope coefficient=3.10, t=4.1,
PB0.01). However, the rate of sensitization in the NOVEL(a) group
was significantly greater than in the HOME+ (a) group (t=4.5,
PB0.05). Furthermore, the latter group did not differ significantly
from the HOME− (a) group. (C) Mean (9S.E.M.) number of rotations
on the amphetamine challenge day. A one-way ANOVA showed there
was a significant effect of group (F=23.1, PB0.0001). Rats in the
NOVEL and HOME+ groups, that were pretreated with amphetamine,
showed a greater rotational response than their respective saline control
groups (Fisher’s PLSD, PB0.05). However, the magnitude of sensi-
tization in the NOVEL(a) group was greater than in the HOME+ (a)
group, as indicated by a significant interaction effect (two-way
ANOVA; effect of drug, F=28.9, PB0.0001; effect of condition,
F=36.5, PB0.0001; effect of drug-by-condition, F=4.1, PB0.05).
Also, the HOME+ (a) and HOME− (a) groups did not differ signifi-
cantly. (D) Mean (9S.E.M.) number of rotations during the first 15
min of the saline challenge test. A one-way ANOVA showed a
significant effect of group (F=15.2, PB0.0001). Rats pretreated with
amphetamine in the NOVEL (Fisher’s PLSD, PB0.0001), but not in
the HOME+ or HOME– groups, showed a conditioned response.
Vibration of the test cages, presentation of the dis-
crete cues, and injections of saline had no measurable
effect on rotational behavior in the HOME− (s) and
HOME+ (s) groups and these groups did not differ from
each other (Fig. 4A). Therefore, the data from these
groups were pooled to yield a single control group
(HOME(s)). As in Experiment 1, exposure to the novel
environment produced a small increase in activity dur-
ing the first 10 min of the first test session, but this
quickly habituated across test sessions (Fig. 5D).
Fig. 5. The mean (9S.E.M.) number of rotations per 5-min interval
in response to the first (light circles) and twentieth injection (dark
circles) of 0.5 mg/kg amphetamine (top panels) or saline (bottom
panels) in the NOVEL, HOME+ or HOME− groups. The asterisks
indicate a significant (PB0.05) difference in rotations between the first
and twentieth test session for each time interval (paired Student’s
t-tests).
Fig. 6. The mean (9S.E.M.) number of rotations per 5-min interval
in response to a challenge injection of 0.5 mg/kg amphetamine (top
panels) or saline (bottom panels). For both the HOME+ and HOME−
groups the saline and amphetamine challenge infusions were paired
with presentation of the light and tone stimuli. The asterisks indicate
a significant (PB0.05) difference in rotations between saline and
amphetamine pretreated groups during each time interval (unpaired
Student’s t-tests).
course of rotational behavior during the amphetamine
(top panels) and saline challenge tests (bottom panels).
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There was again a large effect of treatment condition
on the acute response to amphetamine (Fig. 4A, test
session 1). In the NOVEL(a) group the first injection of
amphetamine produced a large increase in rotational
behavior, which was significantly greater than that ob-
served in all other groups (PB0.01). When the treat-
ment was preceded by the compound stimulus in the
home cages (HOME+ (a)), amphetamine produced a
small, but statistically significant increase in rotational
behavior, relative to the saline control group and this
was significantly greater than that seen in the
HOME− (a) group (Fisher’s PLSD tests, PB0.05). The
latter group did not show a significant increase in
rotational behavior relative to the saline control group.
As in Experiment 1, repeated injections of am-
phetamine given in a distinct test cage (NOVEL(a))
produced robust sensitization, as indicated by a signifi-
cant positive slope coefficient (Fig. 4B; mean9S.E.M.
slope coefficient for the NOVEL(a) group=9.5389
1.774, PB0.0001). Amphetamine treatments signaled
by a discrete stimulus in the home cages also induced
sensitization (mean9S.E.M. slope coefficient for the
HOME+ (a) group=3.10390.75, PB0.05). However,
the rate of sensitization in the NOVEL(a) group was
significantly greater than in the HOME+ (a) group, as
indicated by a significant difference in slope coefficients
(PB0.05, Fig. 4B). This difference in sensitization is
also reflected in the time course data shown in Fig. 5.
After repeated amphetamine treatment animals in the
NOVEL(a) group showed a much greater peak behav-
ioral response and the response was more persistent
than that seen in the HOME+ (a) group (see Fig. 5A,C).
Furthermore, the slope coefficients for the HOME− (a)
were not different from zero (i.e. they did not sensitize)
and the HOME+ (a) and HOME− (a) groups did not
differ.
The results of the amphetamine challenge test were
consistent with the treatment phase of the experiment
(Fig. 4C). Amphetamine-pretreated rats in the NOVEL
and HOME+ conditions both showed a greater rota-
tional response to a challenge injection of 0.5 mg/kg
amphetamine than did saline-pretreated rats, indicating
that these groups sensitized. However, the NOVEL(a)
group showed greater sensitization than the HOME+ (a)
group, as indicated by a significant drug (pretreatment)-
by-condition interaction (PB0.05). The HOME− (a)
group did not differ significantly from the saline control
group or from the HOME+ (a) group.
As in Experiment 1, the rats pretreated with am-
phetamine in the distinct test environment showed a
conditioned response when given a challenge injection
of saline in the drug treatment environment (Fig. 4D
and Fig. 6D). In contrast, rats in the HOME− and
HOME+ conditions did not show a significant condi-
tioned response upon presentation of the compound
stimulus (Fig. 6E,F). The absence of a CR in the
HOME+ (a) group might be due to the fact that in this
experiment the saline control group showed a relatively
large rotational response (compare Fig. 1D for Experi-
ment 1 and Fig. 4D for this experiment). It is possible,
therefore, that the single pairing between amphetamine
and the compound stimulus during the amphetamine
challenge test was sufficient to produce a conditioned
response (Ref. [23] for example). (Note that in this
experiment the saline challenge test was given after the
amphetamine challenge test).
5. Experiment 3
The results of Experiments 1 and 2 indicate that
signaling drug administration with a discrete stimulus
does not promote robust psychomotor sensitization
comparable to that seen when amphetamine treatments
are given in a distinct and relatively novel test environ-
ment. It is possible, however, that contextual stimuli
were especially effective because the test context, in
addition to visual and auditory stimuli, also provided
olfactory cues (e.g. the smell of the corn-cob bedding),
which are a particularly effective CS for rats. Indeed,
Ferger et al. [33] reported that olfactory stimuli, but not
visual or tactile stimuli, elicited a large excitatory condi-
tioned response following pairing with injections of
apomorphine. Similarly, olfactory cues have been re-
ported to provide superior discriminative stimulus
properties in drug self-administration experiments
[50,86]. Therefore, in Experiment 3 we used a com-
pound stimulus consisting of a simultaneously pre-
sented pulsing tone and an odor.
5.1. Methods
Again, the methods and procedures were similar to
those used in Experiments 1 and 2. Briefly, the follow-
ing groups were tested: NOVEL(a) (N=7/6), NOVEL(s)
(N=8), HOME+ (a) (N=9/8), HOME+ (s) (N=5),
HOME− (a) (N=9) and finally HOME− (s) (N=4).
Two rats passed a catheter patency test given after the
last treatment day, but failed the catheter patency test
given at the end of the experiment. Therefore, their
data were used to analyze the acute drug response, and
the development of sensitization, but were excluded
from the statistical analyses of the amphetamine and
saline challenge tests. The treatment phase consisted of
nine consecutive daily i.v. infusions of 0.5 mg/kg am-
phetamine or saline, delivered at a flow-rate of 20
ml/min. The compound stimulus used to signal drug
administration in the HOME groups consisted of the
following. First, the experimenter entered the testing
room and placed a cotton-tip applicator, which had
been impregnated with a peppermint concentrate (dis-
solved in 90% ethanol), into a small container mounted
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Fig. 7. (A) The mean number of rotations (9S.E.M.) during the first,
third, fifth, seventh and ninth test session for rats that received
intravenous injections of saline or 0.5 mg/kg amphetamine. The
groups are the same as in Fig. 1. The first and subsequent injections
of saline produced negligible rotational behavior in all groups. There
were significant group differences on the first test day (F=33.6,
PB0.0001). An acute injection of amphetamine produced a signifi-
cant increase in rotational behavior in the NOVEL group (Fisher’s
PLSD PB0.0001), but not in the HOME+ or HOME− groups. (B)
Presents the results of the linear regression analyses for all groups.
One-sample t-tests indicated that repeated injections of amphetamine
in the NOVEL(a) (mean9S.E.M. slope coefficient=4.8, t=2.3, PB
0.05) and HOME+ (a) (mean9S.E.M. slope coefficient=4.9, t=3.1,
PB0.05) groups produced a significant increase in rotations over test
sessions, i.e. these groups sensitized. Also, these groups did not differ
from one another. (C) Mean number of rotations (9S.E.M.) in
response to an amphetamine challenge injection. A one-way ANOVA
indicated that there was a significant effect of group (F=18.3,
PB0.0001). Rats in the NOVEL(a) group (Fisher’s PLSD, PB
0.0001), but not in the HOME+ (a) and HOME− (a) groups showed a
sensitized response. (D) Mean number of rotations (9S.E.M.) during
the first 15 min of the saline challenge test. A one-way ANOVA
showed a significant effect of group (F=39.7, PB0.0001). Rats
pretreated with amphetamine in the NOVEL(a) and HOME+ (a)
groups (Fisher’s PLSD, PB0.05) showed a conditioned response,
and there was no significant difference in the magnitude of the
conditioned response between these groups.
tests) using the same procedure as in Experiments 1 and
2. Also, the NOVEL groups were treated as in Experi-
ments 1 and 2 (i.e. no tone/olfactory cue was
presented).
Following a 6-day withdrawal period all groups re-
ceived a challenge i.v. infusion of 0.5 mg/kg of am-
phetamine to test for the expression of sensitization,
and the following day a challenge injection of saline
was given to test for the development of a conditioned
rotational response. For the HOME− and HOME+
groups, the challenge injections were again paired with
the presentation of the compound stimulus (on the
saline challenge test the cue was presented throughout
the entire test session).
Rotational behavior was recorded for 90 min in 5
min bins. For the HOME− and HOME+ groups rota-
tions were recorded for an additional 15 min prior to
drug administration.
5.2. Results: Experiment 3
Fig. 7 shows the effects of nine intravenous infusions
of 0.5 mg/kg amphetamine or saline (panel A), a chal-
lenge infusion of 0.5 mg/kg amphetamine (panel C) or
a challenge injection of saline (panel D). For illustrative
purposes Fig. 8 shows the time course of rotational
behavior following the first and ninth injection of am-
phetamine (top panels) or saline (bottom panels) and
Fig. 9 shows the time course of rotational behavior
during the amphetamine (top panels) and saline chal-
lenge tests (bottom panels).
The first injection of saline in the NOVEL environ-
ment again produced a small increase during the first 5
min of the test session, but in contrast to previous
experiments this effect did not disappear with repeated
Fig. 8. The mean (9S.E.M.) number of rotations per 5-min interval
in response to the first (light circles) and ninth injection (dark circles)
of 0.5 mg/kg amphetamine (top panels) or saline (bottom panels).
The asterisks indicate a significant (PB0.05) difference in rotations
between the first and ninth test session for each time interval (paired
Student’s t-tests).
over a small hole in the wall of each test cage. At the
same time the odor stimulus was introduced, the back-
ground white noise signal was turned off and a pulsing
tone (85 dB) was turned on. For the HOME+ groups
the cue was introduced 1 min prior to drug administra-
tion. Following drug administration (20 min) the cotton
tips were removed from the test cages, the pulsing tone
was switched off and white noise resumed. For
HOME− groups cue presentation and drug administra-
tion were always unpaired (except during the challenge
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Fig. 9. The mean (9S.E.M.) number of rotations per 5-min interval
in response to a challenge injection of 0.5 mg/kg amphetamine (top
panels) or saline (bottom panels). For both the HOME+ and
HOME− groups the saline and amphetamine challenge injections
were paired with presentation of the tone and odor stimuli. The
asterisks indicate a significant (PB0.05) difference in rotations be-
tween saline and amphetamine pretreated groups during each time
interval (unpaired Student’s t-tests).
ment (but see below). Repeated treatments with
amphetamine again did not produce sensitization in the
HOME− (a) group, which differed significantly from the
NOVEL(a) and HOME+ (a) groups (PB0.05).
The amphetamine challenge test indicated that rats in
the NOVEL(a) group developed robust sensitization,
whereas the HOME+ (a) group did not (Fig. 7C). These
results provide support for the hypothesis discussed
above that amphetamine did not produce robust sensi-
tization in the HOME+ (a) group and that for some
reason sensitization in the NOVEL(a) was unusually
attenuated during the treatment phase of the experi-
ment. Rats in the HOME− (a) condition again did not
show evidence of sensitization.
The effect of the saline challenge test illustrate that
amphetamine-pretreated rats in both the NOVEL(a) and
HOME+ (a) groups, but not the HOME− (a) group,
showed a conditioned response during the first 15 min
of the test session (Fig. 7D and Fig. 9E,F). Further-
more, there was no significant difference in the magni-
tude of the conditioned response between the
NOVEL(a) and HOME+ (a) groups, as indicated by a
non-significant drug (pretreatment)-by-condition inter-
action (Fig. 7D).
6. Experiment 4
Taken together, the results presented thus far suggest
that pairing discrete stimuli with drug administration in
the home cage is not sufficient to promote the kind of
robust sensitization seen when drug administration is
paired with placement of the animal into a distinct test
environment. Negative results are always troublesome,
however, because it is not possible to ‘prove the nega-
tive’. For example, it is possible that the stimuli we used
were simply not salient to the rats (see Section 8).
Therefore, in a final attempt we decided to test whether
a highly salient, fear-evoking cue (a tone previously
paired with footshock) would promote more robust
sensitization. These experiments are very labor and time
demanding, therefore, in this experiment sensitization
was assessed using only a within-subjects comparison
and two groups: (i) rats that received repeated intra-
venous injections of amphetamine in the home cages in
association with a cue previously paired with footshock
(HOME+ fearful(a)); and (ii) rats that received am-
phetamine injections in association with a cue that had
not been paired with footshock (HOME+ (a)).
6.1. Methods
Following 6-OHDA lesions (but prior to catheter
implantation) rats were housed in the drug treatment
environment for 12 days. During this phase, half of the
rats (N=8) underwent a series of white noise and
exposure to the novel test environment (Fig. 8D). There
were no differences between the HOME− (s) and
HOME+ (s) groups at any time and therefore, these
data were pooled to yield a single control group
(HOME(s)).
There was a large effect of treatment condition on
the acute response to amphetamine (Fig. 7A, 1st test
session). The first injection of amphetamine produced a
large response in the NOVEL(a) group, and this was
significantly greater than in all other groups (Fisher’s
PLSD tests, PB0.01). In contrast, there was no effect
of the first amphetamine injection in either the
HOME+ (a) or HOME− (a) groups; i.e. they did not
differ from the HOME(s) group, or from each other.
As in Experiment 2, repeated injections of am-
phetamine produced a progressive increase in rotational
activity across test sessions in both the NOVEL(a) and
HOME+ (a) groups (Fig. 7A,B), indicating that these
groups sensitized. Furthermore, these groups did not
differ in the rate of sensitization, as indicated by similar
slope coefficients (NOVEL(a) group=4.8492.14, PB
0.05; HOME+ (a) group=4.8891.80, PB0.05). It
should be noted, however, that the slope calculated for
the NOVEL(a) group was unexpectedly small, relative
to the slopes obtained in the previous experiments.
Therefore, is seems reasonable to suggest that the simi-
larity in slopes in the NOVEL(a) and HOME+ (a) groups
was the result of a reduced rate of sensitization in the
NOVEL(a) group, rather than to an increase in sensi-
tization in the HOME+ (a) group. It is unclear why
amphetamine did not produce more robust within-sub-
jects sensitization in the NOVEL group in this experi-
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footshock pairings to establish first-order conditioning
to the auditory cue. For the other half of the rats the
auditory stimulus and shock were unpaired (N=8).
The first in a series of six consecutive daily sessions of
fear conditioning began on day 3. Two fear condition-
ing cages were built from plastic round buckets identi-
cal to those used as drug test cages, except the floor of
each conditioning cage was made of tubular steel rods
(4 mm, diameter) spaced 1.9 cm apart. The grid floor
was wired to a shock source and solid-state grid scram-
bler (Med. Associates, LaFayette, IN), which was pro-
grammed to deliver a 1-s, 1.6 mA footshock (US). The
CS consisted of 60 s of white noise (80 dB) that was
delivered through a speaker mounted to the side of
each cage (:4 cm above the grid floor). The cages
were cleaned with water and 70% ethanol and the trays
containing ground corn-cob bedding were placed un-
derneath the grid floors. For each session the rats were
transported in pairs from their home cages to the fear
conditioning cages located in a nearby testing room.
After placement into the cage (3 min), the rats assigned
to the HOME+ fearful(a) group received a 1 min presenta-
tion of the white noise stimulus immediately followed
by a single footshock. The white noise-shock trial was
repeated 10 times with a 120-s inter-shock interval,
after which the rats were returned to their home cages.
Rats assigned to the HOME+ (a) group (N=8) also
received ten footshocks and white noise presentations,
but the temporal relationship between the white noise
and footshock varied in two ways: either ten consecu-
tive 1 min white noise presentations (30-s inter-tone
interval) were followed by ten consecutive footshocks (1
min inter-shock interval), or ten footshocks were fol-
lowed by ten white noise presentations. To reduce the
likelihood that conditioned fear to the white noise
became dependent on contextual cues (including trans-
port and handling), rats were also exposed at a various
times before and during the fear conditioning phase to
the apparatus, but no footshock or white noise were
presented.
On the day following the final fear conditioning
session (day 9) all rats were implanted with intravenous
catheters. Rats were allowed to recover from surgery in
their home cages for 3 days before the drug treatment
phase of the experiment began. Catheters were flushed
daily with 0.1 ml of heparin solution. During the treat-
ment phase, both groups received nine consecutive daily
intravenous infusions of 0.5 mg/kg of amphetamine
using injection procedures described above (20 ml hep-
arin+15 ml amphetamine+45 ml heparin injected at a
flow rate of 20 ml/min over a 3 min period). For both
groups drug injection was accompanied by three 60-s
presentations of the white noise CS (5 min before the
treatment, at the moment of treatment and 5 min after
the treatment). Thus, for one group drug administra-
tion was signaled by a cue that had been previously
paired with footshock (HOME+ fearful(a)), and for the
other group drug administration was signaled by a cue
that had not been paired with footshock (HOME+ (a)).
As in Experiment 2, the cages were vibrated to be sure
that rats were alert during white noise presentation and
drug administration. Finally, following a 6 day with-
drawal period both groups were given an additional i.v.
challenge infusion of 0.5 mg/kg amphetamine to test for
the long-term expression of sensitization.
6.2. Results: Experiment 4
Fig. 10 (panel A) shows the effects of nine intra-
venous injections of amphetamine in the HOME+ fearful
and HOME+ (a) groups (slope coefficients are presented
in the inset). The first injection of amphetamine pro-
duced a significantly larger acute response when drug
administration was preceded by the fearful cue than
when preceded by the neutral cue (Fig. 10A). Although
no attempt was made to quantify the response to
the CS, casual observation revealed that rats for whom
the white noise had previously been paired with foot-
shock initially exhibited a conditional fear response,
consisting of freezing behavior. Repeated injections
of amphetamine did not produce a significant in-
crease in rotational behavior over test sessions in either
group (mean9S.E.M. slope coefficient for the:
HOME+ fearful(a) group= −0.3991.6; for the
HOME+ (a) group=4.5993.29), and the slopes for the
two groups did not differ significantly. Thus, neither
fearful nor neutral cues were sufficient to promote
psychomotor sensitization when amphetamine was
given in the HOME environment. Furthermore, these
groups did not differ in their rotational response to a
Fig. 10. (A) The mean number (9S.E.M.) rotations during nine test
sessions for rats that received injections of 0.5 mg/kg amphetamine
that were signaled by a white noise stimulus that had previously been
paired with footshock (HOME+ fearful(a)), or by a white noise stimulus
that had not been paired with footshock (HOME+ (a)). The insert
shows the slope coefficients. The first injection of amphetamine
produced a significantly greater response when paired with a fearful
stimulus than when paired with a neutral stimulus (unpaired t-test;
t=2.2, PB0.05). However, neither of these groups showed a signifi-
cant increase in rotational behavior over test sessions. (B and C) The
number of rotations for each 5 min interval during the first and last
test session.
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Fig. 11. (Top panels) The relationship between the acute response to
amphetamine (first test session) and sensitization (slope coefficients)
for all three treatment conditions calculated by conducting linear
correlation analysis on the pooled data from Experiments 1–3. There
were no significant correlations between the acute response to
amphetamine and the rate of sensitization in any of the treat-
ment conditions (Fisher’s r values: NOVEL(a)=0.1, P=0.57;
HOME+ (a)= −0.204, P=0.25; HOME− (a)= −0.08, P=0.69).
(Bottom panels) The relationship between the conditioned response
(Saline challenge) and sensitization (slope coefficients) for all treat-
ment conditions. There were no significant correlations between the
magnitude of the conditioned response and the rate of sensitization in
any of the treatment conditions (Fisher’s r values: NOVEL(a)=0.15,
P=0.42; HOME+ (a)=0.212, P=0.25; HOME− (a)=0.032, P=
0.87).
(slope coefficients) was not significantly related to the
magnitude of the conditioned response on the saline
challenge day.
8. Discussion
In most experiments on sensitization there are many
contextual stimuli associated with drug treatments that
reliably predict drug administration, including removal
from the home cage, handling, transport to a distinct
test environment, stimuli associated with the drug injec-
tion ritual and interoceptive cues produced by the drug
itself. As Siegel ([85], p. 84) has noted, ‘in the absence
of special precautions, the effects of a drug are almost
always signaled by cues uniquely present at the time of
drug administration. For example, piercing the skin
with a hypodermic needle (in the case of parenterally
administered drugs) reliably announces subsequent
pharmacological stimulation’. These cues can have a
large influence on the behavioral effects of psychostim-
ulant drugs. For example, doses of amphetamine, co-
caine or morphine that induce robust sensitization
when given in a distinct test environment, may fail to
induce sensitization when given in the absence of any
environmental cues predictive of drug administration
[11,18,19,26,78]. When higher doses of amphetamine or
cocaine are administered, however, robust sensitization
is induced, regardless of environmental context. That is,
it appears that environmental context shifts the dose-ef-
fect curve for the induction of sensitization [18,19]. This
effect of context is not unique to rotational behavior in
rats with a unilateral lesion of the mesostriatal do-
pamine pathway, because a similar effect is found when
the psychomotor stimulant effects of amphetamine are
quantified by measuring locomotor crossover activity in
neurologically intact rats [5,36]. In the present series of
experiments, we sought to further examine the contri-
bution of treatment-related stimuli in the induction of
sensitization. Specifically, we compared the ability of
contextual cues (a distinct test environment) versus
discrete cues (light, tone and/or odor), paired with drug
administration, to modulate the induction of
sensitization.
The following major findings are reported. (i) Consis-
tent with our previous studies (above for references),
repeated intravenous infusions of 0.5 mg/kg am-
phetamine produced robust psychomotor sensitization
when drug administration was signaled by placement
into a distinct test environment. (ii) The same treatment
regimen failed to produce sensitization when am-
phetamine was given at home in the absence of any
environmental cues predictive of drug administration.
(iii) When drug treatments were given in the home cage,
but were signaled by discrete cues, only modest sensi-
tization was seen. That is, using a within-subjects anal-
challenge injection of amphetamine given after 6 days
withdrawal.
7. The relationship between the initial drug response,
the development of a conditioned response, and the
susceptibility to sensitization
It has been suggested that the effect of environment
(home versus novel) on the initial (acute) psychomotor
response to amphetamine and on psychomotor sensi-
tization can be dissociated [5]. To further explore this
issue, linear correlation analyses were conducted on the
combined data from Experiments 1–3. Fig. 11 (top
panels) presents the results of these analyses and shows
that there were no significant correlations between the
initial drug response and the within-subjects measure of
sensitization (slope coefficients) in any group.
Fig. 11 (bottom panels) shows similar analyses and
demonstrates that the degree of behavioral sensitization
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ysis, sensitization was seen in the HOME+ (a) group in
Experiments 2 and 3 (but not Experiment 1) and using
a between-subjects analysis, sensitization was seen in
Experiments 1 and 2 (but not Experiment 3). However,
in all experiments the magnitude of sensitization in the
HOME+ (a) group was significantly less than that in the
NOVEL(a) group, and there were no significant differ-
ences between the HOME+ (a) and HOME− (a) groups
on the amphetamine challenge test in any experiment.
Taken together, these findings suggest that merely
providing discrete stimuli predictive of drug administra-
tion in the home cage is not sufficient to promote the
robust psychomotor sensitization observed when drug
treatments are given in a distinct and relatively novel
test environment.
The present findings are consistent with a number of
earlier experiments from our group in which rats were
given intraperitoneal injections of amphetamine or co-
caine in either a distinct test environment or in physi-
cally identical cages in which the rats lived [5–7]. In
these experiments there were a number of cues that
reliably signaled drug administration even when drugs
were given at home (e.g. the experimenter entering the
testing room, handling and a needle jab). Rats treated
under these conditions did sensitize, but to a much
lesser extent than when drug treatments were given in a
distinct and relatively novel test environment. Indeed,
the discrete cues used in the present study and the cues
associated with intraperitoneal injections are similar in
many respects. For example, both are relatively simple
discrete foreground stimuli that are presented only
transiently; i.e. they precede and/or only partially over-
lap with the initial pharmacological effects of the drug.
In contrast, by their very nature, contextual cues repre-
sent a global, multidimensional stimulus complex, in-
cluding both foreground and background cues, some of
which precede drug administration by minutes (e.g.
handling and transport), and many of which extend
beyond the initial pharmacological effects of the drug.
8.1. Facilitation of associati6e learning processes by
en6ironmental context
As in the case of contextual control over the expres-
sion of sensitization [1], it is not known how environ-
mental stimuli gain access to the neural substrate that is
sensitized by psychostimulant drugs to modulate the
induction of sensitization [78]. As suggested in the
Introduction, it is possible that exposure to a distinct
test environment promotes robust sensitization because
it facilitates associative learning processes [63,70,91].
Indeed, the current results appear to be consistent with
such an associative learning view of sensitization. Al-
though contextual and discrete cues both elicited a
‘drug-like’ CR following repeated drug treatments, the
CR was typically more robust when contextual cues
signaled drug administration than when discrete cues
signaled drug administration (except Experiment 3). It
is possible, therefore, that sensitization was facilitated
in a distinct test environment because contextual stimuli
were simply more effective CSs, relative to discrete
stimuli, i.e. the ‘associability’ was greater for contextual
stimuli than for discrete stimuli. If this is the case,
however, we need to ask why contextual cues associated
with drug treatments are more effective CSs than dis-
crete cues, and thereby promote more robust psycho-
motor sensitization.
Unfortunately, the published literature provides little
help. There are numerous reports demonstrating drug
conditioning when contextual stimuli are used (for ex-
ample see Refs. [14,22,29,30,45,67,69,80,90]), but only a
few researchers have attempted to investigate the ability
of discrete stimuli to acquire CS properties when the
drugs are administered by the experimenter. Condi-
tioned locomotor activity in response to discrete audi-
tory [14,17] or olfactory [33] stimuli paired with
injections of amphetamine or apomorphine have been
reported, as has conditioned analgesia after pairing an
olfactory stimulus with injections of morphine [93]. The
difficulty in interpreting these studies, however, is that
during conditioning the discrete stimuli were embedded
in a larger context (i.e. drug treatments were given a
distinct test environment). Therefore, these studies
probably demonstrate drug conditioning to both dis-
crete and contextual stimuli. Indeed, this procedure
may potentiate the ‘associability’ of discrete stimuli [4].
To the best of our knowledge only two studies have
been reported in which discrete cues alone have been
paired with experimenter-administered drug. Pickens
and Dougherty [66], who used a procedure very similar
to ours, described a ‘chronic jugular catheter system,
which allowed the drug to be injected automatically
without interfering with the animal’s normal cage
movements’. They reported conditioned locomotor ac-
tivity elicited by a discrete cue (light) after repeated
pairings of the light with methamphetamine administra-
tion. Unfortunately, these authors reported data from
only two rats. More recently, Panlilio and Schindler
[61] reported that discrete cues (tone or light) paired
with injections of cocaine developed the ability to elicit
a conditioned locomotor response. Interestingly, these
authors also reported that the expression of cocaine-in-
duced sensitization came under conditioned control of
the discrete stimulus. Neither of these two studies,
however, directly compared drug conditioning using
contextual versus discrete stimuli, let alone investigated
differences in the ability of such stimuli to promote the
induction of sensitization.
Nonetheless, there are a number of reasons why
contextual stimuli associated with amphetamine admin-
istration might provide a more effective CS and gain
more associative control over the induction of sensitiza-
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tion than discrete stimuli. First, contextual cues associ-
ated with the distinct test environment may have been
more salient than discrete cues. According to the Res-
corla–Wagner model of associative learning [71]
changes in associative strength produced by a CS–US
pairings are dependent, among other things, on the
salience of the CS (Ref. [48] as well). One can imagine
that being taken from the home cage, transported and
then placed into a test environment consisting of many
distinctive stimuli, including olfactory, visual, auditory
and tactile stimuli, provides a more salient stimulus that
a discrete light, tone or odor stimulus. Second, the
unequal associability of contextual versus discrete stim-
uli may have been more fundamental. As noted by
Garcia et al. ([38], p. 795), ‘pairing a perceptible cue
with an effective reinforcer does not insure effective
associative learning; the cue must be appropriate for
the consequences that ensue’. For example, it is well
known that gustatory stimuli are effective CSs when
paired with illness (conditioned taste aversion), but
these stimuli are not effective at eliciting conditioned
fear when paired with footshock. Conversely, visual,
tactile and auditory stimuli (e.g. a distinct environment)
are effective at eliciting conditioned fear when paired
with footshock, but not a conditioned taste aversion
when paired with illness [38]. Thus, it is possible that
contextual stimuli are simply more appropriate for
conditioning drug responses than more discrete stimuli.
For example, because the drug US was relatively long-
lasting, contextual cues by virtue of their long-lasting
and static nature, may have acquired greater associative
strength than the discrete stimuli used in the present
experiments. Of course, only four different discrete
stimuli were tested in the present experiments, and it
might be argued that if we tested different stimuli, using
different pairing parameters, some combination might
prove effective. However, even when a highly salient
cue (tone previously paired with footshock) was used to
signal drug administration, amphetamine still failed to
induce robust sensitization (Experiment 4).
At another level of analysis, the differences between
the ability of discrete versus contextual cues to promote
sensitization might be due to the fact that these stimuli
engage different brain systems [46,55,64]. For example,
electrolytic lesions of the hippocampus disrupt the ac-
quisition and expression of conditional fear to contex-
tual stimuli, i.e. a distinct environment, but not the
acquisition and expression of conditional fear to dis-
crete stimuli, such as tones [51,64]. In contrast, lesions
of the amygdala disrupt fear conditioning to either
discrete or contextual stimuli [55]. Based on these find-
ings, is has been proposed that the hippocampus plays
a particularly important role in conditioning to contex-
tual stimuli, but is not required for conditioning to
discrete stimuli. Many researchers believe that the
hippocampus is important in contextual learning be-
cause it allows for the formation of configural represen-
tations [46], although under some conditions rats
appear to be able to acquire conditioned fear respond-
ing to contextual stimuli through hippocampal-indepen-
dent mechanisms [55]. Therefore, it is possible that the
differences in sensitization as a function of the treat-
ment procedures reported here are related to the fact
that conditioning to contextual cues versus discrete cues
is mediated by different, albeit overlapping neural sys-
tems, one being hippocampal-dependent and one being
hippocampal-independent.
Whatever the case, at first glance the present findings
appear to be consistent with a Pavlovian excitatory
conditioning model of sensitization. Contextual cues
that elicited a large CR produced robust sensitization,
whereas discrete cues elicited only a small CR and
sensitization was only marginally enhanced. However,
closer inspection of the data suggests that a simple
excitatory conditioning model cannot account for the
group differences in sensitization reported here. For
one, the magnitude of the CR was very small in com-
parison with the magnitude of sensitization. Averaged
across experiments, the CR in the NOVEL(a) group was
24.6 rotations and in the HOME+ (a) group was 6.1
rotations. The sensitization related increase in rotations
in these groups was 193.6 and 70.6 rotations, respec-
tively. That is, the CR was only :10% of the sensitized
response.
Second, there were interesting differences in the time
course of the CR and the time course of the sensitized
drug response, especially in the NOVEL(a) group. For
example, the peak CR always occurred in the first 15
min interval after presentation of the CS, whereas
sensitization-related differences in rotational behavior
typically persisted much longer. Furthermore, on the
challenge test day the NOVEL(a) group always showed
a biphasic response; that is, an initial peak in activity
during the first 5 min interval, a small decline in activity
over the next couple of intervals, then a second increase
in activity between 20 and 30 min after drug adminis-
tration. In contrast, the CR decreased monotonically
over the first 15 min after the saline challenge infusion
(compare Panels A and D in Figs. 3, 6 and 9). (As an
aside, it is not clear what accounts for the biphasic
response in amphetamine-induced rotation following
i.v. administration in the NOVEL environment. One
speculation is that the first peak coincides with the
initial release of free dopamine from the cytoplasmic
pool, which is rapidly depleted, and the second peak
coincides with repletion of this pool because of libera-
tion of dopamine from the vesicular pool into the
cytoplasmic pool. It may also be related to recent
observations that ‘sensitized’ amphetamine-stimulated
dopamine release becomes calcium-dependent, unlike
‘normal’ amphetamine-stimulated dopamine release
[49,68,95]).
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Third, the hypothesis that the magnitude of sensitiza-
tion is related to the magnitude of the CR was tested
directly by conducting a correlational analysis. The
results indicated that the rate of sensitization was not
related to the ability of treatment-related cues to ac-
quire excitatory conditioned stimulus properties (Fig.
11). Of course, it could be argued that the magnitude of
the CR was underestimated in the present experiments
because the compound stimulus presented during the
saline challenge test did not adequately reproduce the
entire CS, because it did not include the interoceptive
cues produced by the drug itself [63]. Although, it is
quite possible that the saline challenge underestimated
the magnitude of the CR, it is also clear that interocep-
tive cues themselves are not sufficient to promote the
development of sensitization. When drug treatments
were not signaled by environmental cues (HOME− (a)
group), amphetamine failed to induce sensitization,
even after 20 injections. It seems difficult to imagine,
therefore, that the inclusion of interoceptive cues to the
stimulus complex would make a critical difference.
Finally, in a recent study we manipulated the associa-
bility of contextual cues (a distinct test environment) by
habituating rats to the drug treatment environment
prior to each drug administration [27]. Habituation did
not significantly affect the induction of psychomotor
sensitization, despite the fact that this manipulation
prevented the development of a conditioned response to
contextual cues (and markedly attenuated the acute
response to amphetamine, see also below). Thus, taken
together with the present results, it appears that al-
though the ability of context to facilitate associative
learning likely contributes to the long-term behavioral
and neurobiological consequences of repeated drug
treatments, this contribution appears to be of relatively
minor importance for the induction of sensitization.
This conclusion is consistent with reports by others
indicating that the development of an excitatory CR to
treatment-related stimuli is neither necessary nor suffi-
cient for the induction of sensitization [1,5,30,57].
8.2. Facilitation of non-associati6e processes by
en6ironmental context
An alternative hypothesis is that drug administration
in a distinct and relatively novel test environment pro-
motes robust sensitization through mechanisms unre-
lated to associative learning. That is, novelty could
have modulated the unconditioned stimulus properties
of amphetamine to promote sensitization. This possibil-
ity is particularly germane considering that the environ-
mental manipulations used here also modulated the
acute response to amphetamine. Indeed, we have re-
ported many times that environmental novelty can en-
hance the acute (unconditioned) response to
amphetamine [5–7,9,19,26]. However, the effect of en-
vironment on the susceptibility sensitization appears to
be dissociable from the effect of environment on the
acute response to amphetamine (see Section 6.2). This
suggests that the differences between groups in sensi-
tization are not merely a function of the effect of
environment on the acute response to amphetamine
(see Refs. [5,7,78] for a discussion of this point).
Nevertheless, Badiani et al. [9,10] recently described
an especially compelling example of how environmental
context can modulate the initial neurobiological effects
of amphetamine, and in a way that may be relevant to
the effects reported here. These authors used in situ
hybridization for c-fos mRNA as a marker of neuronal
activation, and reported that the pattern of neuronal
activation in the cortex, in the caudate, in the shell and
core of the nucleus accumbens, and in other subcortical
structures was markedly different when an acute i.p.
injection of amphetamine was given in a novel test
environment, relative to when it was given in the rats’
home cage. The ability of novelty to enhance am-
phetamine-induced c-fos expression in the caudate and/
or nucleus accumbens did not, however, depend on a
facilitation of amphetamine-induced release of do-
pamine in the same brain regions [9]. Furthermore, in a
more recent study these researchers used double in situ
hybridization to determine whether amphetamine in-
duced c-fos in cells also positive for D1 and/or D2
receptor mRNA [10]. These two cell populations are
thought to have different patterns of connectivity,
forming the so-called direct and indirect striatonigral
pathways [39]. It was found that amphetamine given in
the home environment induced a significant increase in
c-fos expression in D1 (but not D2) neurons, whereas
when given in a novel environment amphetamine in-
duced c-fos expression in both D1 and D2 neurons [10].
This raises the possibility that the ability of contextual
stimuli to modulate the susceptibility to sensitization
may be related, at least in part, to its ability to modu-
late the neural circuitry engaged by amphetamine, and
to modulate patterns of immediate early gene expres-
sion [9,10].
Of course, these studies do not address the potential
biopsychological mechanisms by which environmental
context modulates immediate early gene expression on
the one hand, and the acute response to amphetamine
and the induction of psychomotor sensitization, on the
other hand. One possibility, which we have discussed
previously, is that environmental novelty may modulate
both the acute response to amphetamine and suscepti-
bility to sensitization because of some action(s) as a
stressor [5–8,78]. Exposure to a novel environment is a
potent stimulus for activating the hypothalamic-pitu-
itary-adrenal (HPA)-axis [13]. A single exposure to a
novel environment produces an acute increase in corti-
costerone levels [37,60] and in some situations repeated
exposure may produce a progressive increase in plasma
H.S. Crombag et al. / Beha6ioural Brain Research 116 (2000) 1–22 19
corticosterone levels, over-and-above the levels pro-
duced by acute exposure to novelty [41,42]. Further-
more, it is well established that repeated intermittent
exposure to stressors, such a footshock, restraint or
tail-pinch, can sensitize rats to the psychomotor stimu-
lant effects of amphetamine [2,3,74]. It is possible,
therefore, that drug administration in a relatively novel
environment enhanced both the acute response to am-
phetamine and sensitization because this is also associ-
ated with elevated corticosterone levels. Indeed, it has
been suggested that behavioral sensitization to am-
phetamine is critically dependent on corticosteroid re-
ceptor activation [72]. However, Badiani et al. [8] have
reported that adrenalectomy does not attenuate the
effect of environmental novelty on amphetamine sensi-
tization, suggesting that novelty-induced secretion of
glucocorticoid hormones do not contribute significantly
to this effect. Furthermore, Schmidt et al. [81] have
recently reported that changes in HPA-axis functioning,
and concomitant changes in ACTH and corticosterone
are neither necessary not sufficient for the expression of
amphetamine-induced sensitization. Of course, other
stress-related hormones, such as corticotrophin-releas-
ing-hormone (CRH), perhaps acting outside the tradi-
tional HPA-axis, could be involved [21]. This possibility
remains to be tested.
9. Conclusions
In conclusion, the present results show that the abil-
ity of amphetamine to induce psychomotor sensitiza-
tion can be powerfully modulated by environmental
stimuli present at the time of drug administration.
However, this effect appears to be specific to contextual
stimuli. Discrete cues that merely predicted drug ad-
ministration did not facilitate robust psychomotor sen-
sitization. Although the difference between the ability
of contextual versus discrete stimuli to facilitate sensi-
tization may be in part related to differences in their
ability to facilitate associative learning processes, it is
suggested that the effect of a distinct and relatively
novel environment as a stressor may be the critical
factor. However, in a recent experiment we found that
even after habituating rats to a distinct test environ-
ment for 6–8 h prior to each drug administration,
robust sensitization was induced. In contrast, this ma-
nipulation completely abolished the effect of environ-
ment on the acute response to amphetamine [27]. Thus,
whatever stress-related mechanism(s) context affects to
modulate the induction of sensitization, the temporal
dynamics of this effect appear to extend well beyond
the immediate biobehavioral consequences of exposure
to novelty (i.e. they far outlast the initial ‘stress re-
sponse’). Indeed, these results seem difficult to reconcile
with the proposed role of corticosterone secretion in
sensitization in light of the transient increase in corti-
costerone levels typically produced by stressors [37].
Of course, as pointed out by Koolhaas et al. ([52] p.
777), ‘stress induces a cascade of neurobiological pro-
cesses. Each of these processes may have a different
time course ranging from milliseconds, in the case of
direct transduction processes, to minutes, hours and
days when modulatory processes are involved at the
level of DNA transcription and peptide synthesis’.
Thus, one possible scenario is that exposure to a dis-
tinct and relatively novel environment triggers a cas-
cade of cellular processes, presumably including
changes in gene expression. This initial ‘trigger’ may
then leave the brain susceptible to drug-induced neu-
roadaptive processes, perhaps involving growth factors
[34,35], even long after the initial triggering event, and
thereby facilitate the process of behavioral sensitization.
The psychological and neurobiological mechanisms by
which this may occur are unknown, but elucidating
them will be critical in understanding these kinds of
important drug-environment interactions.
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